Global Animal Healthcare Market (Size of $29,537 million in 2014) to Witness 7% CAGR during 2015 - 2020: P&S Market Research

NEW YORK, September 29, 2015 /PRNewswire/ --

The global animal healthcare market is expected to increase from $29,537.4 million in 2014, and reach $44,203.2 million by 2020, with a CAGR of 7.0% during 2015 - 2020. The global animal healthcare market is mainly driven by increasing trend of pet adoption. The adoption of western culture and changing lifestyles in the developing countries, such as India and China, has increased the adoption of pet animals, which in turn is supporting the growth of the animal healthcare market. Pet ownership is one of the major status symbols observed in the developing countries. Cats and dogs are adopted by the people for psychological and therapeutic benefits. India animal healthcare market is expected to witness fastest growth, with a CAGR of 10.1% during 2015 - 2020. The booming trade of meat products and increasing meat consumption has led to upsurge in the production animal's population within the region. There has been a considerable growth in zoonotic diseases, due to the upsurge in the animal population, which has supported the growth of the animal healthcare market in the region.

(Logo: http://photos.prnewswire.com/prnh/20150727/756778 )

Explore Report Description with Detailed ToC on "Global Animal Healthcare Market" at: https://www.psmarketresearch.com/market-analysis/animal-healthcare-market


The evolution of new diseases offers untapped opportunities for the animal healthcare market. To find enhanced solutions for the prevailing and new diseases, the companies in the animal healthcare market are increasing their research and development activities. As the prevention drugs are not available in the market, the recently diagnosed diseases acts as threat for the owners of animal farm. Under such circumstances, they have to follow the natural method of stopping the disease from spreading, as suggested by the veterinarians and the animal health boards. One such disease is porcine epidemic diarrhea virus (PEDV), which is caused by corona virus. It leads to infection in the cell lining within the small intestine of pigs.

The information and data in the publication "Global Animal Healthcare Market Size, Share, Development, Growth and Demand Forecast to 2020" represent the research and analysis of data from various primary and secondary sources. P&S Market Research analysts and consultants interact with leading companies of the concerned domain to substantiate every value of data presented in this report. The company bases its primary research on discussions with prominent professionals and analysts in the industry, which is followed by informed and detailed online and offline research.

Request For Report Sample: https://www.psmarketresearch.com/enquiry-form.php?enqid=497&title=Report%20sample

The vaccines segment is expected to grow fastest, with a CAGR of 6.1%, during 2015 - 2020 in the global animal healthcare market. As the population of pets is increasing, the animal bite cases have also gone up, thus increasing the chances of disease transfer to human population. This concern has acted as a support to the growth of the vaccines market.

Some of the transmissible diseases, such as zoonosis, in vertebrate animals can be transferred indirectly or directly to humans. If consumers digest worm through undercooked or raw infected fish, then they can get infected through anisakiasis. The increasing prevalence of zoonotic and food borne diseases has raised the concern of animal farm owners, and pet owners regarding the health of their animals. In the U.S. and other countries, brucellosis (bacterial infection) is increasing and it can cause still birth or abortion in animals. The bacterial infection generally affects goats and livestock animals, such as cows and sheep.

Browse Related Research at: https://www.psmarketresearch.com/industry-report/consumer-products

The major companies operating in the global animal healthcare market include Zoetis Inc., Merck & Co. Inc., Merial Limited, Bayer AG, Virbac SA, Ceva Sante Animale S.A., Boehringer Ingelheim GmbH, Elanco Animal Health Inc., and Vetoquinol S.A.

ANIMAL HEALTHCARE MARKET SEGMENTATION

Animal Healthcare by Product

Pharmaceuticals
Feed Additives
Vaccines


Animal Healthcare by Animal Type

Companion Animals
Production Animals


GEOGRAPHICAL SEGMENTATION

Animal Healthcare Market by Region

North America
The U.S.
Rest of North America
Europe
Germany
France.
Italy
The U.K.
Rest of Europe
Asia-Pacific
China
India
Australia
Rest of Asia-Pacific
Rest of the World (ROW)
Brazil
Others

Browse More Reports

Organic Food and Organic Beverages Market - https://www.psmarketresearch.com/market-analysis/organic-food-and-organic-beverages

Frozen Bakery Market - https://www.psmarketresearch.com/market-analysis/frozen-bakery-market

Spices and Seasonings Market - https://www.psmarketresearch.com/market-analysis/spices-and-seasonings-market

About P&S Market Research

P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.

As one of the top growing market research agency, we're keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.

Contact:
Ms Somya
Manager - Client Partner
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: [email protected]
Web: https://www.psmarketresearch.com

SOURCE P&S Market Research

Suggested Articles

Pfizer spinoff Zoetis met Q2 expectations and brightened its full-year forecast, but it's looking to M&A to drive further growth.

Fresenius’ new CEO has pulled off a dealmaking double play, committing more than $5.4 billion to expand its reach in both sterile generics and in biosimilars.

Bayer’s pharma products have been growing lickety-split, and its 2016 numbers show just how—and how much. But with the big Monsanto merger top of mind at Bayer…